Furthermore, this nuclear role of CtsL in breast cancer cells has been shown to play an important role in cancer resistance to treatment [49], thus offering the possibility of designing novel approaches aimed at sensitising cancer cells to conventional chemotherapy and radiotherapy approaches aimed at inducing DNA damage. This evidence concerns the gene CTSL and breast carcinoma.